SOFTWARE Magazine: Healthcare BPO - IMS shares benefits, trend of outsourcing within the healthcare industry

Jan 06, 2016, 14:48 ET from IMS Health

NEW YORK, Jan. 6, 2016 /PRNewswire/ -- The article excerpt below from SOFTWARE Magazine, written by Cassandra Balentine, focuses on IMS Health (NYSE: IMS) as well as the benefits and trends of outsourcing business processes within the healthcare industry.


The evolving healthcare industry benefits from automation in business processes, enabling organizations to make informed decisions, engage patients, and maximize the value of software investments.

A recent study of the Global Healthcare Business Process Outsourcing (BPO) by Research and Markets, Global Healthcare BPO Market 2015 – 2019, indicates growth at a compound annual growth rate of 5.32 percent over the period of 2014 to 2019.

IMS Health Holdings Inc. is a global information and technical services company that provides end-to-end propriety applications and configurable solutions including BPO. The company ranked number 57 in the 2015 Software 500, a revenue-based ranking of software and software services companies.

Based in Danbury, CT, the publicly held company reported $2,641 million in software and services revenue for the 2014 fiscal year.

To view the entire article as it appears on SOFTWARE Magazine click here:

About IMS Health

IMS Health (NYSE: IMS) is a leading global information and technology services company providing clients in the healthcare industry with end-to-end solutions to measure and improve their performance. Our 7,500 services experts connect configurable SaaS applications to 10+ petabytes of complex healthcare data in the IMS One™ cloud platform, delivering unique insights into diseases, treatments, costs and outcomes. The company's 15,000 employees blend global consistency and local market knowledge across 100 countries to help clients run their operations more efficiently. Customers include pharmaceutical, consumer health and medical device manufacturers and distributors, providers, payers, government agencies, policymakers, researchers and the financial community.

As a global leader in protecting individual patient privacy, IMS Health uses anonymous healthcare data to deliver critical, real-world disease and treatment insights. These insights help biotech and pharmaceutical companies, medical researchers, government agencies, payers and other healthcare stakeholders to identify unmet treatment needs and understand the effectiveness and value of pharmaceutical products in improving overall health outcomes. Additional information is available at